TA Associates invests in MedEnvision
Belgian orthopedic surgery medtech company MedEnvision takes a strategic growth investment from TA Associates alongside its founders, management and existing partner Smile Invest.
TA Associates has made a strategic growth investment in MedEnvision, a Belgian medtech company that helps orthopedic surgical teams work more efficiently in the operating theatre. MedEnvision's founders, management and current financial partner Smile Invest are also involved in the transaction.
The investment is intended to support MedEnvision's long-term growth strategy, which centers on continued international expansion, broadening its product portfolio and further building out its commercial organization. Goodwin Procter advised TA Associates, with a team led by Arvin Abraham.
Deal facts
- Target
- MedEnvision
- Business
- Belgian medtech company whose products help orthopedic surgical teams work more efficiently in the operating theatre
- Buyer
- TA Associates
- Sponsor
- TA Associates
- Deal type
- Investment
- Status
- Announced, not yet closed
- Announced
- Wednesday, October 21, 2026
Sources
- Goodwin Procter LLPOct 27, 2026
Written by Buyout Desk from the sources above. Spotted an error? Email corrections@buyoutdesk.com.